The company expired its plan on November 17, 2022
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,603 KRW | -0.43% |
|
+3.89% | -5.82% |
2023 | Wonbiogen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Tranche Update on Wonbiogen Co., Ltd.'s Equity Buyback Plan announced on May 16, 2022. | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.82% | 41.31M | |
+13.03% | 28.43B | |
+26.03% | 2.62B | |
+27.04% | 2.44B | |
-46.52% | 2.26B | |
-30.82% | 2.02B | |
+34.44% | 1.99B | |
-21.96% | 1.59B | |
+13.79% | 1.38B | |
+32.97% | 1.33B |
- Stock Market
- Equities
- A307280 Stock
- News Wonbiogen Co., Ltd.
- Wonbiogen Co., Ltd.'s Equity Buyback announced on May 16, 2022, has expired with 1,485,877 shares, for KRW 2,995.7 million.